Exchange: NASDAQ·Updated 11:28 AM EDT
IRWD logo

IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

$3.58
$0.075
(2.14%)
Today
EarningsNov 9
Mkt Cap$578.34M
Vol329,423.00

About IRWD

Ironwood Pharmaceuticals, Inc. is a biotechnology company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
60

Bullish Sentiment

How do you feel about IRWD?

dnpro
$IRWD PE 4.6x and Market of +/-500M$ This could go back easily to X5! Sometimes there are some of these opportunities... $SPY $XBI $QQQ $BTC.X
5
wtzou
$IRWD No ill will, but I hope every day that I wake up to Tom McCourt getting canned, probably with a fantastic exit package but who cares, don't let the door hit you on the way out you worthless piece of sh*&^%*&^.
1
2
StockTwitsGhost
$IRWD The "strategic review" has dragged on for over a year while value bleeds out. Stop stalling and make a deal. AbbVie already shares Linzess economics, so sell the company with Linzess to them at $5+ a share and then sell apraglutide to Zealand or Takeda for $2-3 per share upfront plus a $5 CVR. This path beats burning cash on another trial while Linzess runway shrinks. Pick one, sign it, and give shareholders their money back before there's nothing left. "Exploring alternatives" isn't a plan. Get it done.
5
ZeeBearish
$IRWD Friends of the IRWD ST message board, we need to have the talk. I suffer from IDS. Will you stand with me?
4
Solaf
$IRWD “Tammi was instrumental in driving the turnaround of LINZESS® this year, returning it to blockbuster status and growth.” Mate, she was the Chief Commercial Officer of a company whose only commercialized asset was being marketed and sold by AbbVie. So what exactly was she chiefing?
3
StockTwitsGhost
$IRWD Nice thesis but the stock is $3.75 for a reason. The street views and assigns little to no value to Apra. Linzess gained approval and Ironwood’s success was built on its original 2007 licensing partnership with Forest Laboratories and the strategic execution of its former management, while today’s management has squandered that foundation and demonstrated little ability to create comparable value for shareholders. Apra has little to no chance of commercial success as a standalone Ironwood asset.
1
cert
$IRWD why this stock crashing so much compare to other small cap bio ? Is there any catalyst which can save this going down 4-5% each day ?
1
raylin
$IRWD From the Q2 ER, expect STARS2 to finish well before the info on clinical trials website.
3
Bio_Invest101
$IRWD Slowly but surely moving higher high. Stay focused and don’t let the bashers lunatics distract you.
3
Solaf
$IRWD I don't know Tammi but I'm 100% certain the market won't like another internal CEO appointment. We saw exactly how that played out with McCourt.
2
Solaf
$IRWD Whether driven by greed or sheer incompetence, management failed to sell the company when market conditions were favorable. Now the tides have turned, winter has come, and we’re all left to suffer the consequences.
2
StockTwitsGhost
$IRWD $3.86 close. Since the board made Tom McCourt permanent CEO on June 1, 2021, and kept him there, today, October 9, 2026, marks the 280th week for IRWD shareholders, and the board that has repeatedly stood by him bears responsibility for it. Happy Friday friends.
2
ZeeBearish
$IRWD Friends of IRWD! Two things: 1) Lindsay, the golden IRWD cow, remains healthy & grazing in the field, and 2) everyone needs to stop acting like a tween going through their first breakup. The glp-2 sky is not falling. Sorry there’s a little cloud passing over IRWD at the moment. When the sun comes out it will illuminate the updated market & the refined apra opportunity. Your IRWD mama wishes you sweet dreams & round, bright pumpkins as we head into ACG week!
2
stockytradah
$IRWD crashing because the biggest competitor glepaglutide got approved in Europe. They will capture the market 3-4 years before Apra can come on. Game over
2
ASKING7
$IRWD short interest out today with record high. On the technical side, we have been consolidating for around 9 months to build up the new base. It is way longer than I thought but I have no problem with it, longer it is the more solid the base will become and more room for the upside. The main question is when is the next major catalyst for us, got the feeling some new real word data might release on the coming ACG 2026. Or we might need wait and see the Q3 earnings. Keep calm, the WAVE might be coming 🍀
2
ZeeBearish
$IRWD SHOCKED that the *3* stooges of the IRWD ST message board showed up within 30 min of each other to 💩 on the new CEO. THIS IS WHAT YOU’VE BEEN DREAMING OF FOR YEARS!!! Did you really think that an outsider was even an option to take over the helm?!? You *three* are just bizarrely miserable. Move on!
1
raylin
$IRWD Stunned! Did he leave willingly? If not, should have relieved him long ago. CMO to CEO is unusual in my experience. Hope this is a move to sell this to a capable organization. 🤞
1
focafoca99
$IRWD confirms new CEO Tammi Gaskins will take the helm Jan 1, 2027 as board expands to nine directors.
1
wtzou
$IRWD Current MC is $593.21M Is that overpriced if apraglutide is worthless? Being honest here. The market is saying apra is worth $500M extra (low I know) but what is the rest worth?
1
wtzou
$IRWD added more here, but keeping powder available for the real drop Remember the 1.50s?
1

Advertisement|Remove ads.